Health Sciences
The Cardiac Rehabilitation Outcome Study (CROS)
The prognostic effect of cardiac rehabilitation in the era of acute revascularization and statin therapy: a systematic review and meta-analysis of randomized and non-randomized studies. The Cardiac Rehabilitation Outcome Study (CROS).
The research project aims to:
- investigate the effectiveness of cardiovascular rehabilitation (CR) in reducing total mortality and other clinical events during follow-up after an acute coronary syndrome (ACS) in the era of acute revascularization and intense medical therapy including statins
- investigate the effectiveness of CR in reducing total mortality and other clinical events during follow-up after coronary bypass grafting (CABG) in the era of intense medical therapy including statins
- evaluate essential cardiac rehabilitation conditions and characteristics with respect to their influence on clinical outcome. These include: timing of the start of CR after the index event (ACS or CABG), CR-duration, CR intensity.
Funding
| Funder: | Pfizer |
| Start date: | November 2013 |
| End date: | May 2015 |
| Amount: | £15,000 |
Collaborators
Internal members:
External Collaborators:
- Bernhard Rauch
- Jean-Paul Schmid
- Heinz Völler
- Massimo Piepoli
- Costas Davos
- Katrin Jensen
- Daniel Saure
- Maria-Inti Metzendorf
Contact details
Karen
Cardy
Research Administrator and Academic Secretary to Professor Patrick Doherty
Tel:
01904 32(1385)
karen.cardy@york.ac.uk